Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
750 participants
OBSERVATIONAL
2019-06-15
2019-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Periodontitis in Sample of Egyptian Population
NCT05317208
Prevalence of Periodontitis Based Upon Principles Presented by the 2017 Classification: A Hospital-based Cross-sectional Study on a Sample of Young Egyptian Dental Patients
NCT05441397
Prevalence of Periodontitis on a Sample of Adult Egyptian Population
NCT03901911
Correlation Between Periodontitis and Hypertension Among a Sample of Adult Egyptian Patients
NCT04634734
Prevalence of Periodontitis in Diabetic Patients of Egyptian Population
NCT05322369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the last 30 years, the classification of periodontitis has been repeatedly upgraded in an attempt to align it with emerging scientific evidence. The workshop agreed that, consistent with current knowledge on pathophysiology, three forms of periodontitis can be identified: necrotizing periodontitis, periodontitis as a manifestation of systemic disease and the forms of the disease previously known as "chronic" or "aggressive", now grouped under a single category, "periodontitis".In revising the classification, the workshop agreed on a classification framework for periodontitis further characterized based on a multidimensional staging and grading system that could be adapted over time as new evidence emerges
Staging is largely dependent upon the severity of disease at presentationas well as on the complexity of disease management.While,grading provides supplemental information about biological features of the disease, including a history based analysis of the rate of disease progression, assessment of the risk for further progression, anticipated poor outcomes of treatment, and assessment of the risk that the disease or its treatment may negatively affect the general health of the patient
Staging involves four categories (stages 1 through 4) and is determined after considering several variables including clinical attachment loss, amount and percentage of bone loss, probing depth, presence and extent of angular bony defects, furcation involvement,tooth mobility and tooth loss due to periodontitis.
Stage III \& IV are characterized by interdental clinical attatchment loss \> 5mm and radiographic bone loss extending to the middle or apical third of the root. In stage III, four teeth or less are lost while in stage IV, five teeth or more are lost due to periodontitis. In addition to stage II complexity, Stage III is characterized by probing depth greater than or equal 6 mm, vertical bone loss greater than or equal 3mm, furcation involvement class II or III and moderate ridge defect. In addition to stage III complexity, stage IV is characterized by severe ridge defect , bite collapse, drifting and flaring.
The study aims at determining the prevalence of Periodontitis Stage III \& IV in adult Egyptian dental outpatients attending the diagnostic centre at faculty of Dentistry, Cairo University
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient consulting in the outpatient clinic
* Provide informed consent.
Exclusion Criteria
* Patients diagnosed with psychiatric problems or intoxicated with alcohol or drugs
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omar Khaled Gamil Moussa Megahed
Master postgraduate student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry , Cairo Univeristy
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21252461
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.